Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Shook

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 2, 2000
Comparison of intravenous midazolam with pentobarbital for sedation for head computed tomography imagingD M Moro-Sutherland, J T Algren, P T Louis, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptorsJ E Shook, W Kazmierski, W S Wire, et al.
Proceedings of the Western Pharmacology Society|January 1, 1985
The effects of neurotensin on gastrointestinal motility in rodentsE A Ayres, J T Fulginiti, F Porreca, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functionsJ E Shook, J T Pelton, P K Lemcke, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
Structure-activity analysis of five constrained somatostatin like peptides with opioid antagonist propertiesW S Wire, J T Pelton, W Kazmierski, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
The proenkephalin A fragment peptide E is metabolized centrally to a novel peptide with opioid activityT P Davis, J E Shook, T J Gillespie, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1987
Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitroJ E Shook, J T Pelton, W S Wire, et al.
International Journal of Peptide and Protein Research|June 1, 1988
Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residueE E Sugg, M Serra, J E Shook, et al.
Life Sciences|November 3, 1986
Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33E E Sugg, J E Shook, M Serra, et al.
NIDA Research Monograph|January 1, 1986
Comparison of the opioid antagonist properties of a cyclic somatostatin analog in vitro and in vivoJ E Shook, J T Pelton, W Kazmierski, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 2, 2000
Comparison of intravenous midazolam with pentobarbital for sedation for head computed tomography imagingD M Moro-Sutherland, J T Algren, P T Louis, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptorsJ E Shook, W Kazmierski, W S Wire, et al.
Proceedings of the Western Pharmacology Society|January 1, 1985
The effects of neurotensin on gastrointestinal motility in rodentsE A Ayres, J T Fulginiti, F Porreca, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functionsJ E Shook, J T Pelton, P K Lemcke, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
Structure-activity analysis of five constrained somatostatin like peptides with opioid antagonist propertiesW S Wire, J T Pelton, W Kazmierski, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
The proenkephalin A fragment peptide E is metabolized centrally to a novel peptide with opioid activityT P Davis, J E Shook, T J Gillespie, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1987
Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitroJ E Shook, J T Pelton, W S Wire, et al.
International Journal of Peptide and Protein Research|June 1, 1988
Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residueE E Sugg, M Serra, J E Shook, et al.
Life Sciences|November 3, 1986
Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33E E Sugg, J E Shook, M Serra, et al.
NIDA Research Monograph|January 1, 1986
Comparison of the opioid antagonist properties of a cyclic somatostatin analog in vitro and in vivoJ E Shook, J T Pelton, W Kazmierski, et al.
Pageof 5